EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 121 filers reported holding EPIZYME INC in Q1 2022. The put-call ratio across all filers is 4.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,875,000 | -27.6% | 2,500,000 | +651.5% | 0.01% | -45.0% |
| Q3 2020 | $3,969,000 | +121.4% | 332,673 | +198.0% | 0.02% | +66.7% |
| Q2 2020 | $1,793,000 | -80.6% | 111,620 | -84.8% | 0.01% | -75.0% |
| Q2 2019 | $9,237,000 | -32.5% | 735,988 | -33.4% | 0.05% | -22.6% |
| Q1 2019 | $13,688,000 | +92.9% | 1,104,800 | +65.1% | 0.06% | +113.8% |
| Q3 2018 | $7,095,000 | +181.5% | 669,300 | +259.8% | 0.03% | +190.0% |
| Q2 2018 | $2,520,000 | -81.1% | 186,000 | -75.2% | 0.01% | -82.1% |
| Q1 2018 | $13,313,000 | +784.0% | 750,000 | +525.0% | 0.06% | +700.0% |
| Q4 2017 | $1,506,000 | -91.4% | 120,000 | -87.0% | 0.01% | -91.1% |
| Q3 2017 | $17,591,000 | +52.0% | 923,400 | +91.5% | 0.08% | -1.2% |
| Q2 2015 | $11,570,000 | -26.7% | 482,100 | -42.6% | 0.08% | -25.9% |
| Q1 2015 | $15,779,000 | +276.2% | 840,200 | +443.0% | 0.11% | +237.5% |
| Q3 2014 | $4,194,000 | – | 154,721 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |